Additionally, oncogenic KRAS was shown to increase nuclear factor (erythroid-derived 2)-like 2 (NRF2) expression which further protects cancer cells from reactive oxygen species (ROS)-induced toxicity [22]. Here, NFE2L2 is linked to cancer.